Immunostimulant In Situ Hydrogel Improves Synergetic Radioimmunotherapy of Malignant Glioblastoma Relapse Post‐Resection

S Sun, W Gu, H Wu, Q Zhao, S Qian… - Advanced Functional …, 2022 - Wiley Online Library
Tumor recurrence remains the major cause of management failure after surgical resection of
glioblastoma (GBM). Immunotherapy has the potential to effectively eradicate tumors and …
被引用次数：28 相关文章

Immunostimulant In Situ Hydrogel Improves Synergetic Radioimmunotherapy of Malignant Glioblastoma Relapse Post‐Resection.

S Sun, W Gu, H Wu, Q Zhao, S Qian… - Advanced …, 2022 - search.ebscohost.com
Tumor recurrence remains the major cause of management failure after surgical resection of
glioblastoma (GBM). Immunotherapy has the potential to effectively eradicate tumors and …